Agilent Technologies Acquires Kalabie Electronic Laboratory Notebook from Klee Group
News Jun 19, 2007
Agilent Technologies Inc. has announced it has acquired the Klee Group’s Kalabie Electronic Laboratory Notebook (ELN). The focus for this product, which is Agilent’s first electronic notebook, will be on the pharmaceutical market and some chemical applications. Financial details of the acquisition were not disclosed.
Kalabie ELN is a configurable software solution for the R&D sector, used by pharmaceutical and dermo-cosmetic companies since 2004 to boost productivity and enhance collaboration of chemistry and biology scientists.
A digital laboratory notebook, Kalabie ELN provides a foundation for knowledge and process management as well as intellectual property protection within laboratories. Kalabie ELN centralizes and secures all data from experimental work with a high level of traceability. Offering a rich package of features plus flexibility, Kalabie ELN can be deployed as a standard packaged solution or it can be configured to meet customers’ specific needs.
Agilent’s current portfolio of laboratory software includes OpenLAB -- the operating system for the laboratory. Agilent plans to integrate the Kalabie ELN product into OpenLAB in the next six months to provide customers with the ability to manage computing resources in the laboratory with a complete solution.
“With the addition of Kalabie, Agilent can provide customers with a complete software solution and a single-vendor approach to their laboratory management needs,” said Bruce von Herrmann, vice president and general manager for Agilent’s Software and Informatics Division. “ELNs simplify knowledge and data integration. The combined capabilities of Kalabie ELN, OpenLAB and GeneSpring provide unique capabilities that enhance productivity.”
“Integrating into Agilent’s software and informatics portfolio is exciting for the Kalabie ELN team,” said Alain Meller, Kalabie director at the Klee Group. “This will immediately provide our customers the benefits of Agilent’s global reach and support capabilities, allowing for rapid deployment of ELN solutions across organizations and geographies. Moreover, with the combined capabilities that Agilent OpenLAB offers, we will speed up our ability to market and deliver high-value, global, integrated lab informatics solutions where the ELN is a key component.”
Prior to its acquisition by Agilent, Kalabie was a division of Klee Group, an information system consulting firm founded in 1987.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018